REGISTR BOSTON Scientific Rhythm Management REGISTR (SOCRATES) (SOCRATES)
VĚDECKÝ REGISTR SPRÁVY RYTMU BOSTON
SOCRATES is part of Boston Scientific's (BSC) Post-market surveillance system. The implementation of such systems is mandatory per local regulations such as the Regulation '(EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices' or short Medical Device Regulation (MDR). The SOCRATES design is therefore based on the BSC's commitment as well as external regulatory requirements to proactively and systematically gather, record and analyze relevant data on the quality, performance and safety of devices throughout their entire lifetime.
Přehled studie
Postavení
Postavení
Podmínky
Podmínky
Intervence / Léčba
Intervence / Léčba
Detailní popis
SOCRATES is a non-randomized, multisite, single-arm, open-label, global post-market observational data collection per standard of care. While generally of prospective design, a limited retrospective element is allowed for the inclusion of patients for a short period of 10 days after their index procedure.
SOCRATES intends to enroll a number of subjects that will support the analysis of all the individual Post Market Clinical Follow-Up (PMCF) Plans. An average of approximately 100 subjects per year and site on a continuous basis is expected but may vary depending on the needs of individual PMCF Plans. As long as SOCRATES is active, there is no upper limit to the total number of subjects that may be enrolled, and enrollment will be driven by the need to support sample sizes of individual PMCF plans for given products/product groupings supported by SOCRATES.
SOCRATES is designed to be a continuous effort after the data collection commences without a predefined closure timepoint. Data collection and enrollment may be stopped, restarted or finalized per Sponsor discretion.
The expected duration of SOCRATES participation for a subject is dependent on
- the specific lifetime of the device (e.g. the battery usage for pulse generators or continued active use of leads for CRM devices) or
- the necessary timeframe to adequately assess safety and performance of the device based on the residual risk assessed for each device in the associated PMCF plan. Timeframes might e.g. spread from 7 days to one year post procedure for EP. The maximum duration per enrolled subject will consequently vary.
For BSC implantable devices subjects are intended to be followed for the entire time of being implanted with a BSC device to allow data collection over the lifetime of the device(s) as required by applicable regulations. A maximum duration per enrolled subject is not defined, unless locally required. In case a local maximum duration is enforced subjects may be consented again and re-enrolled for continued participation if they are still in scope for SOCRATES. Sites shall ensure continuous data collection without any gaps in case a re-enrollment becomes applicable. Data sets for re-enrolled subjects will be handled as if the subject was continuously enrolled. This process will ensure to meet the requirement of MDR for device manufacturers to collect data over the lifetime of the devices.
Typ studie
Typ studie
Zápis (Odhadovaný)
Zápis
Kontakty a umístění
Studijní kontakt
Studijní kontakt
- Jméno: Maria Paz Lopez-Chicharro
- Telefonní číslo: 1-800-227-3422
- E-mail: maria.lopez-chicharro@bsci.com
Studijní záloha kontaktů
- Jméno: Jens B Goetzke, Dipl.Ing.
- Telefonní číslo: 1-800-227-3422
- E-mail: Jens.Goetzke@bsci.com
Studijní místa
-
-
-
Jette, Belgie, 1090
- Nábor
- Universitair Ziekenhuis Brussel
-
Kontakt:
- Carlo de Asmundis, Prof.
-
Yvoir, Belgie, 5530
- Nábor
- CHU UCL Namur - Site Godinne
-
Kontakt:
- Dominique Blommaert, Prof.
-
-
-
-
-
Brest, Francie, 29200
- Nábor
- CHRU de Brest, Hôpital de la Cavale Blanche
-
Kontakt:
- Jacques Mansourati, Prof.
-
Clermont-Ferrand, Francie, 63000
- Nábor
- CHRU de Clermont-Ferrand
-
Kontakt:
- Romain Eschalier, MD
-
Lomme, Francie, 59462
- Nábor
- Hopital Saint Philibert
-
Kontakt:
- Aymeric Menet, MD
-
Pau, Francie
- Nábor
- CHG de Pau
-
Kontakt:
- Hugues Bader, MD
-
Saint-Etienne, Francie, 42055
- Nábor
- CHU de Saint-Etienne
-
Kontakt:
- Antoine Da Costa, Prof.
-
-
-
-
-
Dublin, Irsko, D07 WKW8
- Nábor
- Mater Private Hospital
-
Kontakt:
- Gabor Szeplaki, Prof.
-
-
-
-
-
Modena, Itálie, 41124
- Nábor
- Policlinico di Modena
-
Kontakt:
- Giuseppe Boriani, Prof.
-
Roma, Itálie, 00168
- Nábor
- Policlinico Universitario Agostino Gemelli
-
Kontakt:
- Gemma Pelargonio, MD
-
Roma, Itálie, 00169
- Nábor
- Policlinico Casilino
-
Kontakt:
- Leonardo Calò, MD
-
Roma, Itálie, 00186
- Nábor
- Ospedale S.G. Calibita Fatebenefratelli - Isola Tiberina
-
Kontakt:
- Stefano Bianchi, MD
-
-
-
-
-
Ramat Gan, Izrael, 52621
- Nábor
- Sheba Medical Center
-
Kontakt:
- Roy Beinart, MD
-
Tel Aviv, Izrael, 6423906
- Nábor
- Tel Aviv Sourasky Medical Center
-
Kontakt:
- Raphael Rosso, Professor
-
Tel Aviv, Izrael, 62431
- Nábor
- Tel Aviv Sourask Medical Center
-
Kontakt:
- Raphael Rosso, Professor
-
-
-
-
Quebec
-
Québec, Quebec, Kanada, G1V 4G5
- Nábor
- Institut Universitaire de Cardiologie et de Pneumologie de Quebec
-
Kontakt:
- Jean-Francois Sarrazin, MD
-
-
-
-
-
Berlin, Německo, 12687
- Nábor
- Unfallkrankenhaus Berlin Marzahn
-
Kontakt:
- Corinna Lenz, MD
-
Bochum, Německo, 44791
- Dokončeno
- Augusta Kranken Anstalt GmbH
-
-
-
-
-
London, Spojené království, EC1A 7BE
- Nábor
- St. Bartholomew's Hospital
-
Kontakt:
- Ross Hunter, Prof.
-
Manchester, Spojené království, M13 9WL
- Nábor
- Manchester Heart Center
-
Kontakt:
- Charles Pearman, MD
-
-
-
-
-
Athens, Řecko, 17674
- Nábor
- Onassis Cardiac Surgery Center
-
Kontakt:
- Michael Ephremidis, MD
-
Athens, Řecko, 11527
- Dokončeno
- General Hospital of Athens "G. Gennimatas"
-
-
-
-
-
Madrid, Španělsko, 28040
- Nábor
- Hospital Clinico San Carlos
-
Kontakt:
- Nicasio Pérez Castellano, MD
-
San Cristóbal de La Laguna, Španělsko, 38320
- Nábor
- Hospital Universitario de Canarias
-
Kontakt:
- Francisco Bosa Ojeda, MD
-
Santa Cruz de Tenerife, Španělsko, 38010
- Nábor
- Hospital Nuestra Señora de La Candelaria
-
Kontakt:
- Luis A. Acosta, MD
-
Zaragoza, Španělsko, 50009
- Nábor
- Hospital Universitario Miguel Servet
-
Kontakt:
- Antonio Asso Abadía, MD
-
-
Kritéria účasti
Kritéria způsobilosti
Kritéria způsobilosti
Věk způsobilý ke studiu
- Dítě
- Dospělý
- Starší dospělý
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Metoda odběru vzorků
Studijní populace
The subjects will be recruited from the general patient population of the participating centers who are
- receiving diagnosis or treatment using a BSC product in scope of SOCRATES and
- fulfilling all inclusion criteria and none of the exclusion criteria.
Popis
Inclusion Criteria:
- Subject is willing and capable of providing informed consent and/or to give approval to collect/store/process personal health information by the sponsor or such consent/approval is provided by a legally designated representative, if required by local law or regulation.
- Subject is (one criterion must be fulfilled) a. prospectively scheduled for a procedure involving i. use of a BSC EP Ablation product or BSC Capital Equipment product or ii. a BSC CRM product implant or b. retrospectively enrolled no more than 10 days after the index procedure and all data necessary for appropriate reporting of all past visits is available and complete including i. the procedure where being diagnosed or treated with at least 3 separate BSC EP Ablation products/components or BSC Capital Equipment products/components or ii. the BSC CRM product implant.
Exclusion Criteria:
- Subject is foreseen not to be followed at the enrolling center for at least 1 year after an implant procedure (CRM) or at least 1 month (EP).
- Subject is receiving diagnosis or therapy by means of any product, that is not approved for commercial use at the time of implant/procedure.
Studijní plán
Jak je studie koncipována?
Detaily designu
- Observační modely: COHORT
- Časové perspektivy: OTHER
Počet skupin / kohort
Kohorty a intervence
Skupina / kohortaSkupina / kohorta |
Intervence / LéčbaIntervence / Léčba |
|---|---|
|
BSC Product Use
Subject fulfilling one of the following conditions: a. prospectively scheduled for a procedure involving i. use of a BSC EP Ablation product or BSC Capital Equipment product or ii. a BSC CRM product implant or b. retrospectively enrolled no more than 10 days after the index procedure and and all data necessary for appropriate reporting of all past visits is available and complete including i. the procedure where being diagnosed or treated with at least 3 separate BSC EP Ablation products/components or BSC Capital Equipment products/components or ii.the BSC CRM product implant. |
In the scope of the CRM procedure and subsequent follow-up, the registry will provide information on the use of the Boston Scientific CRM products/components and combination of those products/components with competitor product(s) per hospital's standard of care. In the scope of the EP procedure and subsequent follow-up, the registry will provide information on the use of the Boston Scientific Electrophysiology products/components and capital equipment products and combination of those products/components with competitor product(s) per hospital's standard of care. |
Co je měření studie?
Primární výstupní opatření
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
System-related complication free rate
Časové okno: From Cardiac Rhythm Management (CRM) device implant on day 0 through follow-up up to 10 years; from electrophysiological (EP) procedure on day 0 through follow-up from 30 days up to 1 year
|
Freedom from complications related to system |
From Cardiac Rhythm Management (CRM) device implant on day 0 through follow-up up to 10 years; from electrophysiological (EP) procedure on day 0 through follow-up from 30 days up to 1 year
|
|
Rate of product related performance deficiencies per product or product group
Časové okno: CRM implant on day 0; EP procedure on day 0
|
Performance of product/product group at implant/procedure |
CRM implant on day 0; EP procedure on day 0
|
|
Rate of product related performance deficiencies per product or product group
Časové okno: CRM implant on day 0 through the implanted duration up to 10 years
|
Performance of product/product group through the implanted duration |
CRM implant on day 0 through the implanted duration up to 10 years
|
Spolupracovníci a vyšetřovatelé
Sponzor
Sponzor
Vyšetřovatelé
Vyšetřovatelé
- Ředitel studie: Eszter Pais, MD, Boston Scientific Corporation
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Začátek studia
Primární dokončení (Odhadovaný)
Primární dokončení
Dokončení studie (Odhadovaný)
Dokončení studie
Termíny zápisu do studia
První předloženo
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
První zveřejněno
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Poslední zveřejněná aktualizace
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
Další identifikační čísla studie
Další identifikační čísla studie
- SOCRATES - C2157
Plán pro data jednotlivých účastníků (IPD)
Plánujete sdílet data jednotlivých účastníků (IPD)?
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .